VERICEL CORPORATION Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
VERICEL CORPORATION (VCEL) reported Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-13.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants · last filed 2017-03-13
- VERICEL CORPORATION stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2016-12-31 was -$190.00K.
- VERICEL CORPORATION stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2015-12-31 was $0.00.
- VERICEL CORPORATION stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- VERICEL CORPORATION stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- VERICEL CORPORATION stock and warrants issued during period, value, preferred stock and warrants for fiscal 2016 was $0.00.
- VERICEL CORPORATION stock and warrants issued during period, value, preferred stock and warrants for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- VERICEL CORPORATION stock and warrants issued during period, value, preferred stock and warrants for fiscal 2014 was $965.00K.
- VERICEL CORPORATION stock and warrants issued during period, value, preferred stock and warrants for fiscal 2013 was $0.00.
| Period end | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 3 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 6 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 6 month as first filed | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 9 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 9 month as first filed | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month as first filed | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 285 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 291 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 294 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 297 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 300 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | -$190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $0.00 10-K · filed 2017-03-13 | ||||||||||
| 2016-09-30 | $190.00K 10-Q · filed 2016-11-07 | |||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $0.00 derived: sum of 3 quarters · filed 2017-03-13 | $0.00 10-K · filed 2017-03-13 | ||||||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $0.00 10-Q · filed 2015-11-13 | $0.00 derived: sum of 4 quarters · filed 2017-03-13 | ||||||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $0.00 10-Q · filed 2015-08-12 | $0.00 derived: sum of 3 quarters · filed 2017-03-13 | $816.00K derived: sum of 4 quarters · filed 2017-03-13 | ||||||||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-14 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $816.00K derived: sum of 3 quarters · filed 2017-03-13 | $820.00K derived: sum of 4 quarters · filed 2017-03-13 | ||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $816.00K derived: sum of 2 quarters · filed 2017-03-13 | $820.00K derived: sum of 3 quarters · filed 2017-03-13 | $965.00K 10-K · filed 2017-03-13 | -$965.00K 10-K · filed 2015-03-25 | |||||||
| 2014-09-30 | $816.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $820.00K derived: sum of 2 quarters · filed 2015-11-13 | $965.00K 10-Q · filed 2015-11-13 | -$965.00K 10-Q · filed 2014-11-13 | $965.00K derived: sum of 4 quarters · filed 2015-11-13 | |||||||
| 2014-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $149.00K 10-Q · filed 2015-08-12 | -$149.00K 10-Q · filed 2014-08-14 | $149.00K derived: sum of 3 quarters · filed 2015-08-12 | $149.00K derived: sum of 4 quarters · filed 2015-08-12 | |||||||
| 2014-03-31 | $145.00K 10-Q · filed 2015-05-14 | $145.00K derived: sum of 2 quarters · filed 2015-05-14 | $145.00K derived: sum of 3 quarters · filed 2015-05-14 | $10.53M 10-Q · filed 2014-05-15 | ||||||||
| 2013-12-31 | $0.00 derived: 10-K 297 month − 10-Q 294 month · filed 2014-03-13 | $0.00 derived: sum of 2 quarters · filed 2014-03-13 | $0.00 10-K · filed 2016-03-14 | -$10.38M 10-K · filed 2014-03-13 | ||||||||
| 2013-09-30 | $0.00 derived: 10-Q 294 month − 10-Q 291 month · filed 2013-11-12 | -$10.38M 10-Q · filed 2013-11-12 | ||||||||||
| 2013-06-30 | -$10.38M 10-Q · filed 2013-08-07 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | -$2.03M derived: sum of 2 quarters · filed 2015-03-25 | -$10.38M 10-K · filed 2015-03-25 | -$10.38M 10-K · filed 2013-03-18 | ||||||||
| 2012-09-30 | -$2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$10.38M 10-Q · filed 2013-11-12 | ||||||||||
| 2012-06-30 | -$8.36M 10-Q · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |